Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Charly50on May 18, 2022 4:41am
109 Views
Post# 34691404

RE:RE:RE:RE:Sad day

RE:RE:RE:RE:Sad day
Exactly !
The collaboration with Evotec, making Sernova risk-free, will attract institutional investors
attract institutional investors. In contrast to private investors, they do not act irrationally, but in a calculated
and steadily until they have built up their position. We need these large numbers as a hedge, so to speak, and to counter the short intentions. The "big ones"
will also expand and increase their positions as science progresses. It is not the private investors who make the prices and blindly buy and sell when the market gives a quick 15%.
So to see yesterday. Fast times 15% profit bagged.
Private investors like to do that. I do not want to evaluate it.
Institutional pursue long-term big goals, after they have analyzed professionally before.
Yesterday's news will make pharma and institutional stop.
I think the journey is just beginning now. "The little tree has been shaken again vigorously";
weak hands have given.
We need the listing... TSXand let's see what the analysts say the next few days!
 
 
<< Previous
Bullboard Posts
Next >>